|Covington & Burling has appointed Shaoyu Chen as managing director of the firm’s China food and drug practice. His experience in food and drug law includes serving as assistant chief counsel in the US Food and Drug Administration’s Office of Chief Counsel, as senior counsel at California-based Amgen Inc, and as chief compliance counsel for GE Healthcare (China). Chen advises international pharmaceutical, biotechnology, medical device, food, dietary supplement, and cosmetic companies about policies from the FDA and State Food Drug Administration in China. He also advises clients on legal issues pertaining to preclinical research, clinical trials, marketing approval, advertising and promotion, good manufacturing practice, pharmacovigilance, import and export, and compliance with FCPA and the China Anti-Unfair Competition Law. A native of China, Chen received his undergraduate degree from Peking University in 1985 and his law degree from the University of Nebraska College of Law in 2000.
Orrick, Herrington & Sutcliffe has appointed William Chun Fai Woo as a partner, based in Hong Kong. With more than a decade of experience in the region, Woo focuses on representing issuers and underwriters in regulatory and corporate matters involving Hong Kong listed companies. He has worked on some of Hong Kong’s largest and highest profile capital markets transactions, including representing the H share underwriters in the US$8.9 billion A and H share rights offering of Bank of China Ltd, and representing the underwriters in the HK$1.73 billion (US$223m) IPO on the HKSE of Trony Solar Holdings Company Ltd, a thin-film solar power photovoltaic module manufacturer based in China, in October 2010. Woo received his MA and LL.B from Cambridge University and is admitted to practice law in England and Wales and in Hong Kong. In 1997, he joined the Hong Kong office of a leading UK law firm where he practised for 11 years and became a partner, followed by two years as a partner with a leading US law firm.